OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam ‘enhancer’Akihiro Morinaka, David M. Livermore|Journal of Antimicrobial Chemotherapy|2015Cited by 167